Workflow
Ponce De Leon Foundation Awarded Grants in the Amount of $635,000 to Nonprofits
Globenewswire· 2026-01-08 21:58
Core Insights - The Ponce De Leon Foundation awarded $635,000 in grants to various nonprofits, bringing its total contributions since 2017 to over $3.6 million [1][10]. Grant Distribution - Aid for Aids International Inc received $20,000 for the Trauma-Informed Psychoeducational Groups Project [2]. - Andromeda Community Initiative was awarded $20,000 for the Construction Career Pathways Program [2]. - Astoria/Queens SHARE-ING & CARE-ING received $20,000 for the Pathways to Prevention: Inclusive Cancer Education & Services for Queens Communities [2]. - Braata Productions Inc was granted $20,000 for After-school & Senior Center Programming [3]. - Bridge Street Development Corp received $25,000 for BSDC Older Adult Services [3]. - Bronx Arts Ensemble Inc was awarded $20,000 for the BAE Professionals Musicians Wages Concert Series [3]. - Brooklyn Children's Museum received $20,000 for Cultural Festivals 2026 [3]. - Center for Supportive Schools was granted $30,000 for Advancing Student Leadership Through When Students Lead & AI Literacy a PS 23/Mahatma K. Gandhi School [3]. - Daniel's Music Foundation received $20,000 for The 7 Annual Danny Awards [4]. - Dream Dare to Revitalize Education thru Arts & Mediation was awarded $20,000 for Making Action Plans for Success [4]. - Educational Video Center Inc received $15,000 for Youth Media Arts & Credible Educators Program [4]. - Emma's Torch Ltd was granted $20,000 for Building Economic Mobility for Low Income Refugees through Culinary Education [4]. - First Jamaica Community & Urban Development Corp received $20,000 for the FJCUDC Food Expansion Program [4]. - Giving Alternative Learners Uplifting Opportunities Inc was awarded $20,000 for the Therapeutic Riding Program for Seniors-Silver Saddles [5]. - Internationals Network for Public Schools Inc received $20,000 for Internationals Financial Literacy Course Development Project [5]. - Jersey City Theatre Center Inc was granted $30,000 for The JCTC Global Arts Education Program [5]. - Legal Action Center of the City of New York Inc received $20,000 for Fair Housing for New Yorkers with Convictions Program [5]. - LIFT Inc was awarded $20,000 for LIFT-New York Coaching Program [5]. - Neighbors Helping Neighbors Inc received $20,000 for Building Stability for Brooklyn Homeowners Program [6]. - New Heights Youth, Inc was granted $20,000 for the College Bound Program [7]. - Opportunities for a Better Tomorrow received $25,000 for Clearing the Path to Employment Program [7]. - Palisades Emergency Residence Corp was awarded $30,000 for Case Management Program [7]. - Part of the Solution, Inc (POTS) received $20,000 for the ESOL Program [7]. - POINT Community Development Corp was granted $20,000 for Youth Arts Education Program [7]. - Renaissance Youth Center received $15,000 for Renaissance Youth Center STEM Learning Adventures Program [7]. - The Carter Burden Center for the Aging Inc was awarded $20,000 for Essential Services for East Harlem Older Adults [8]. - The Neighborhood Self Help by Older Persons Project (SHOPP) received $20,000 for SHOPP Senior Community Assistance Project [8]. - The Possibility Project was granted $20,000 for The Possibility Project's Performing Arts Programs for Youth Empowerment [8]. - The Washington Headquarters Association, New York Morris-Jumel Mansion Inc received $15,000 for Outreach School Programs [8]. - Union City Music Project, Inc was awarded $15,000 for 2026 After School Orchestral Music Programs for Hudson County Kids [9]. - Women for Afghan Women received $15,000 for Senior Programs [9]. Foundation Background - The Ponce De Leon Foundation is a private 501(c)3 charitable corporation established in 2017, funded by a gift from Ponce Bank [10]. - The foundation's mission is to enhance the quality of life in communities served by Ponce Bank, which operates 13 branches in the New York Metro area [11]. - Ponce Bank has $3.2 billion in assets and is recognized as one of the largest Latino-led Minority Depository Institutions and Community Development Financial Institutions in the nation [11].
Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments
Globenewswire· 2026-01-08 21:45
Core Insights - Praxis Precision Medicines, Inc. has announced key leadership appointments to enhance its strategic direction as it prepares for commercial launch and late-stage development [1][2] Leadership Appointments - Jeffrey B. Kindler has been appointed to the board, bringing extensive experience in enterprise leadership and strategic transactions from his tenure as former chairman and CEO of Pfizer [3] - Stuart Arbuckle joins the board with a strong background in global commercial success, having spent 13 years at Vertex Pharmaceuticals, where he played a pivotal role in the company's growth [5] - Megan Sniecinski has been promoted to Chief Operating Officer, responsible for operationalizing the company's growth strategy and overseeing program strategy and operations [8][9] - Dr. Steven Petrou has been promoted to President of Research & Development, reflecting the company's transition into late-stage development with multiple programs advancing toward commercialization [9][10] Strategic Vision - The leadership changes are aimed at optimizing value-creation pathways for Praxis as it enters a critical phase of growth, focusing on commercial launch planning and execution readiness [2][4] - The company is positioned to become a leading CNS company with a pipeline of multi-billion dollar drugs and innovative therapies targeting severe neurological disorders [7] Pipeline and Development - Praxis has a diversified CNS portfolio, including multiple clinical-stage product candidates, and is leveraging genetic insights to develop therapies for both rare and prevalent neurological disorders [12]
Cellectis Announces 2026 Strategy and Catalysts
Globenewswire· 2026-01-08 21:30
Core Insights - Cellectis is focusing on advancing its late-stage allogeneic CAR-T therapies, particularly lasme-cel and eti-cel, with significant clinical trials and partnerships expected to drive growth in 2026 [2][3][4]. Clinical Development - The pivotal Phase 2 trial for lasme-cel in relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL) has commenced, with interim data anticipated in Q4 2026 [2][3]. - Lasme-cel has shown a 68% overall response rate (ORR) and a 56% complete remission rate in early trials, indicating strong efficacy [5]. - The NATHALI-01 trial for eti-cel in relapsed/refractory non-Hodgkin lymphoma (NHL) reported an 88% ORR and a 63% complete remission rate, with further data expected in Q4 2026 [6]. Strategic Partnerships - Cellectis is collaborating with AstraZeneca to develop up to 10 novel cell and gene therapy products targeting high unmet medical needs, leveraging Cellectis' gene editing and manufacturing capabilities [4]. Financial Position - The company projects that its cash reserves will sustain operations into the second half of 2027, indicating a stable financial outlook [8]. Upcoming Events - Cellectis management will participate in the J.P. Morgan Healthcare Conference from January 12-15, 2026, for investor meetings [9].
Copa Holdings Announces Fourth Quarter Financial Results Release Schedule
Globenewswire· 2026-01-08 21:30
PANAMA CITY, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Copa Holdings, S.A. (NYSE: CPA) announces the following events: Earnings Release – Fourth Quarter 2025Date:February 11, 2026Time:After US market closeThis release will be available on our website:ir.copaair.com/financial-information/quarterly-results Earnings Conference Call and Webcast Date:February 12, 2026Time:11:00 AM US ET (11:00 AM Local Time)Join by phone:Click hereWebcast (listen-only):ir.copaair.com/events-and-presentations<td style="text-align: left ...
Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026
Globenewswire· 2026-01-08 21:30
GAITHERSBURG, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) announced it has received a delivery order valued at up to $21.5 million from the U.S. Department of War to supply BioThrax® (Anthrax Vaccine Adsorbed) in 2026. This order is under Emergent’s existing indefinite-delivery/indefinite-quantity (IDIQ) contract (W911SR24D0001), led by the Capability Program Executive Chemical, Biological, Radiological and Nuclear Defense (CPE CBRND), previously the Joint Program Executiv ...
Verisk Announces Sale of its Marketing Solutions Business to ActiveProspect
Globenewswire· 2026-01-08 21:30
Transaction reinforces Verisk’s focus on global insurance and capital allocation disciplineJersey City, NJ, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Verisk (Nasdaq: VRSK), a leading strategic data analytics and technology partner to the global insurance industry, today announced it has sold Verisk Marketing Solutions (VMS) to ActiveProspect, the leading consent-based marketing platform. VMS, part of Verisk’s underwriting division, provides leading marketing solutions for customers in both insurance and non-insuran ...
Postal Realty Trust, Inc. Provides Fourth Quarter and Full Year 2025 Update
Globenewswire· 2026-01-08 21:25
Core Insights - Postal Realty Trust, Inc. acquired 216 properties for approximately $123 million in 2025, reflecting a 20% growth in its asset base from year-end 2024 [2][3] - The company maintains a strong balance sheet with 89% of its debt set to fixed rates and no debt maturities until 2028 [6] Acquisition Activity - In 2025, the company acquired 216 properties leased to the USPS, totaling approximately 642,000 net leasable square feet with a weighted average rental rate of $16.24 per square foot [2] - For the fourth quarter of 2025, the company acquired 65 properties for approximately $29.1 million, comprising about 142,000 net leasable square feet at a weighted average cash capitalization rate of 7.5% [4] Portfolio and Financial Metrics - As of December 31, 2025, the company's portfolio was 99.8% occupied, consisting of 1,917 properties across 49 states and one territory, with approximately 7.1 million net leasable square feet [5] - The weighted average rental rate for occupied properties was $11.88 per square foot, with $14.09 for last-mile and flex properties, and $4.23 for industrial properties [5] Debt and Capital Structure - At year-end 2025, 89% of the company's outstanding debt was fixed rate, with a weighted average interest rate of 4.38% [6] - The company raised gross proceeds of $12.6 million and $48.4 million through its at-the-market offering program by issuing shares at average prices of $15.63 and $15.34, respectively [7] Share Count - As of December 31, 2025, there were 34,104,349 fully diluted shares outstanding, with a weighted average fully diluted share count of 33,620,211 for the fourth quarter [8]
Enact to Host Fourth Quarter 2025 Earnings Call February 4th
Globenewswire· 2026-01-08 21:20
RALEIGH, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) announced it will issue its fourth quarter earnings release after the market closes on February 3, 2026. Enact will host a conference call to review fourth quarter 2025 financial results on February 4, 2026 at 8:00 a.m. (ET). Enact’s earnings release, summary presentation and financial supplement will be available through the company's website, https://ir.enactmi.com/, at the time of their release to the public. Part ...
BGIN BLOCKCHAIN LIMITED Announces Share Purchases by Chairman and Independent Director
Globenewswire· 2026-01-08 21:15
SINGAPORE, Jan. 09, 2026 (GLOBE NEWSWIRE) -- BGIN BLOCKCHAIN LIMITED (“BGIN” or the “Company”; NASDAQ: BGIN), a digital asset technology company with proprietary cryptocurrency mining technologies and a manufacturer of cryptocurrency mining hardware, today announced that the chairman of its board of directors and co-founder of the Company, Oisin Li, and its independent director, Paul Tsang, had purchased additional Class A ordinary shares of the Company in the open market. Mr. Li acquired an aggregate of 6 ...
TransUnion's 2026 Mortgage Pricing Goes Live – Prioritizing Lower Costs for Homebuyers
Globenewswire· 2026-01-08 21:15
Core Insights - TransUnion has launched a revised mortgage pricing model featuring VantageScore® 4.0, aimed at enhancing the mortgage market's safety and cost-effectiveness [1][3] - The new model offers a significant pricing advantage, with VantageScore 4.0 available for $4 per score in 2026, representing a 60% discount compared to FICO scores [1][3] - The introduction of VantageScore 4.0 is expected to lower costs for lenders and consumers while maintaining underwriting costs at 2025 levels [1][3] Company Overview - TransUnion is a global information and insights company with over 13,000 employees operating in more than 30 countries, focusing on providing reliable consumer representations in the marketplace [7] - The company aims to empower consumers and businesses through innovative solutions that extend beyond core credit services into marketing, fraud, risk, and advanced analytics [7] Industry Context - The mortgage industry has historically been constrained by FICO's monopoly, which has led to increased lending costs due to significant royalty hikes from FICO [3] - TransUnion's approach of bundling credit data with VantageScore 4.0 is designed to reduce costs and provide lenders with a more manageable pricing structure [3][5] - The new model is expected to enhance access to loans for qualified homebuyers while ensuring the safety and soundness of the U.S. mortgage market [5]